Order Article Reprints

Marco DN, Salas MQ, Gutiérrez-García G, Monge I, Riu G, Carcelero E, Roma JR, Llobet N, Arcarons J, Suárez-Lledó M, et al. Impact of Early Intrapatient Variability of Tacrolimus Concentrations on the Risk of Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide. Pharmaceuticals. 2022; 15(12):1529. https://doi.org/10.3390/ph15121529

Marco, Daniel N., María Queralt Salas, Gonzalo Gutiérrez-García, Inés Monge, Gisela Riu, Esther Carcelero, Joan Ramón Roma, Noemí Llobet, Jordi Arcarons, María Suárez-Lledó, and et al. 2022. "Impact of Early Intrapatient Variability of Tacrolimus Concentrations on the Risk of Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide" Pharmaceuticals 15, no. 12: 1529. https://doi.org/10.3390/ph15121529

Marco, D. N., Salas, M. Q., Gutiérrez-García, G., Monge, I., Riu, G., Carcelero, E., Roma, J. R., Llobet, N., Arcarons, J., Suárez-Lledó, M., Martínez, N., Pedraza, A., Domenech, A., Rosiñol, L., Fernández-Avilés, F., Urbano-Ispízua, Á., Rovira, M., Brunet, M., & Martínez, C. (2022). Impact of Early Intrapatient Variability of Tacrolimus Concentrations on the Risk of Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide. Pharmaceuticals, 15(12), 1529. https://doi.org/10.3390/ph15121529